Download or read book Drugs Affecting Lipid Metabolism written by Rodolfo Paoletti and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 467 pages. Available in PDF, EPUB and Kindle. Book excerpt: The recent symposium and the appearance of this new book on Drugs Affecting Lipid Metabolism take place at a very unusual time for the development of this area. After the publication and wide acceptance of the results of the cholestyramine study by the Lipid Clinics in the USA, showing for the first time a direct association between drug induced reduction of plasma levels of total and LDL cholesterol and coronary heart disease in a high risk population, an unparalleled interest in drugs and other procedures able to control plasma cholesterol levels has been activated. Two other significant events occurred during 1986 and 1987: the availability of compact instruments for the immediate determination of total cholesterol in plasma or total blood and the developments of new agents such as the inhibitors of HMG-CoA (hydroxymethyl glutaryl CoA) reductase and ACAT inhibitors, with potentially great effect on plasma lipid levels after oral administration. These new advances, together with the combined efforts of cell biologists and lipoprotein chemists, have set the pace for an exciting period of research and clinical applications of diets and drugs af fecting lipids. This volume, which includes the work of many of the leading world laboratories, represents an authoritative and up-to-date ap praisal of the status of the art and a stimulus to future research at laboratory and clinical level in an area of opportunity for clinical and preventive medicine.
Download or read book Drugs Affecting Lipid Metabolism VIII written by David Kritchevsky and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 503 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in 1960, each successive meeting has broken new ground in the field of pharmacological control of lipid levels - offering new and stimulating insights and exposing the audience to the state of the art. The field has progressed sufficiently to permit discussion of the cellular biology of athero sclerosis. The opening session was devoted to pathology, macrophages, lipoproteins and their receptors and choles terol ester metabolism. Because of the recent emergence of new apolipoprotein technology, a workshop devoted sole ly to apolipoprotein methodology was introduced followed by a plenary session devoted to their metabolism and structure. Another rapidly developing area of atherosclerosis research is non-invasive assessment of this condition. Accordingly, a session was devoted to new techniques for this research modality. The final plenary sessions were devoted to the roles of drugs and diet in athero~ scl~rosis - cause, treatment and mechanisms of action. The meeting was summarized by Dr. O.J. Pollak, one of the "founding fathers" of this field. There were nine sessions of proffered papers whose abstracts appear in this volume. In addition, special workshops (to be reported elsewhere) were devoted to several drugs including Oiyzanol, Probucol and Etofibrate.
Download or read book Drugs Affecting Lipid Metabolism X written by Antonio M. Gotto and published by . This book was released on 1990 with total page 602 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism written by Antonio M. Gotto and published by Springer. This book was released on 1996-08-31 with total page 728 pages. Available in PDF, EPUB and Kindle. Book excerpt: Even a brief scan of the table of contents of the present volume is enough to disclose the diversity of research interests and opinions in the field of lipidology. It is precisely this diversity that is the strength of our field and that was showcased by the XII International Symposium of DRUGS AFFECTING LIPID METABOLISM (DALM). The papers published here from these proceedings may be divided into three categories: those that define-and refine---our understanding ofthe clinical benefit of aggressive lipid management, those that develop our knowledge of ris!. assessment, and those that discuss the genetic, bio~hemical, and biophysical mechanisms underlying the pathology of coronary heart disease. On the clinical front, further analysis of the results of the Scandinavian Simvastatin Survival Study (4S) has indicated the cost-effectiveness of therapy in patients with established coronary heart disease. The West of Scotland Coronary Prevention Study (WOSCOPS), whose methodology was described at the DALM XII symposium, has demonstrated in a mostly primary-prevention population what 4S demonstrated for secondary prevention the year before: aggressive lipid-regulating therapy reduces coronary heart disease morbidity and mortality rates without concurrently increasing mortality from noncardiovascular causes. In the future, important considerations will be to develop protocols that maximize benefit in groups underrepresented in traditional clinical research for example, women and the elderly-and to improve compliance to existing treatment regimens. Furthermore, antioxidant, omega-3 fatty acid, and gene therapies warrant further investigation.
Download or read book Drugs Affecting Lipid Metabolism written by Silvio Garattini and published by . This book was released on 1961 with total page 620 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs affecting lipid metabolism proceedings written by Milan Symposium on Drugs Affecting Lipid Metabolism and published by . This book was released on 1961 with total page 624 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs affecting lipid metabolism proceedings ed written by International Symposium on Drugs Affecting Lipid Metabolism, 3rd, Milan, 1968 and published by . This book was released on with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism written by David Kritchevsky and published by North-Holland. This book was released on 1980 with total page 412 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism written by W. Holmes and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 671 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Lipid Metabolism and Atherosclerosis written by David Kritchevsky and published by Springer. This book was released on 1978-11 with total page 464 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume comprises the proceedings of the sixth International Symposium on Drugs Affecting Lipid Meta bolism. Since the first of these symposia in 1960 these triennial meetings have been devoted to the exploration of new ideas, new data and new concepts related to lipid metabolism and atherosclerosis. The sixth Meeting was particularly stimulating in this regard. The concept of the "protective" action of HDL was thoroughly explored within the framework of its molecular biology with data on its epidemiological as well as its in vitro mechan ism(s) of action being discussed. The action of drugs on arterial and HDL metabolism was also discussed as were newer aspects of platelet aggregation, especially as related to prostaglandins. New ground was also broken in discussions of lipid mobilization and mechan isms of hypocholesteremia. We are indebted to the many organizations who con tributed generously to the support of this meeting. Among the sponsors, the assistance of the Lorenzini Foundation was especially helpful. As in all meetings of this type, the hard work of the local organizing committee was instrumental in its success. We are grateful to Mrs. Caroline Hyatt and Mr. Ralph Hollerorth for their invaluable help in the secretariat. We are also deeply indebted to Miss Jane T. Kolimaga for her expert assistance in the preparation of this volume. David Kritchevsky Rodolfo Paoletti William L. Holmes vii Contents LIPOPROTEINS AND DRUGS Lipoprotein Metabolism - New Insights from Cell Biology. . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 D. Steinberg Lipoprotein Metabolism in Man. . . . . . . . . . . . . . . . . . . .
Download or read book Drugs Affecting Lipid Metabolism written by David Kritchevsky and published by . This book was released on 1965 with total page 520 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism VIII written by David Kritchevsky and published by . This book was released on 1985-07-01 with total page 520 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs affecting lipid metabolism written by International Symposium on Drugs and published by . This book was released on 1967 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism written by and published by . This book was released on 1967 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism Cholesterol and atherosclerosis Plasma triglycerides and lipoproteins Drugs affecting plasma lipids written by David Kritchevsky and published by . This book was released on 1967 with total page 540 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism written by W. Holmes and published by . This book was released on 2014-09-01 with total page 696 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Affecting Lipid Metabolism X written by Antonio M. Gotto and published by . This book was released on 1990 with total page 575 pages. Available in PDF, EPUB and Kindle. Book excerpt: Since the most recent conference in Florence (1986), we have witnessed a tremendous expansion in the interest of blood lipids and drugs that have applications for lipid disorders and atherosclerosis. The proceedings of the conference in Houston not only reviews the development of new agents, but also focuses on the recent discovery of new applications for old drugs, including the anti-oxidant effect of procubol in animals, as well as the current state of cholesterol research and atherosclerosis.